MHIP vs. SBIO
MHIP (Milliman Healthcare Inflation Plus ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both Health & Biotech Equities funds. MHIP is actively managed, while SBIO is passively managed. Their 0.45 correlation means their historical movements had little consistent relationship. MHIP charges 0.55%/yr vs 0.50%/yr for SBIO.
Performance
MHIP vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
MHIP
- 1D
- 0.51%
- 1M
- 0.74%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
SBIO
- 1D
- 1.11%
- 1M
- 1.94%
- 6M
- 22.77%
- YTD
- 25.89%
- 1Y
- 94.72%
- 3Y*
- 28.40%
- 5Y*
- 7.98%
- 10Y*
- 10.80%
- ALL TIME*
- 9.31%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $444.11 | $1.02K | $5.73K | |
| $2.54M | $3.67M | $2.13M |
MHIP vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
MHIP Milliman Healthcare Inflation Plus ETF | 0.54% |
SBIO ALPS Medical Breakthroughs ETF | 13.60% |
Correlation
The correlation between MHIP and SBIO is 0.45, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026 | 0.45 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MHIP vs. SBIO — Risk / Return Rank
MHIP
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
SBIO
MHIP vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Milliman Healthcare Inflation Plus ETF (MHIP) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MHIP | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.46 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 7.52 | — |
| Martin ratioReturn relative to average drawdown | — | 20.21 | — |
Loading charts...
Drawdowns
MHIP vs. SBIO - Drawdown Comparison
The maximum MHIP drawdown since its inception was -3.09%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for MHIP and SBIO.
Loading charts...
Drawdown Indicators
| MHIP | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -3.09% | -63.06% | +59.97% |
Max Drawdown (1Y)Largest decline over 1 year | — | -12.66% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -42.44% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -52.49% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.06% | — |
Current DrawdownCurrent decline from peak | -1.08% | -6.47% | +5.39% |
Average DrawdownAverage peak-to-trough decline | -1.34% | -28.17% | +26.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 4.70% | — |
Volatility
MHIP vs. SBIO - Volatility Comparison
Loading charts...
Volatility by Period
| MHIP | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 9.80% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 23.83% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 11.14% | 30.77% | -19.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 11.14% | 33.88% | -22.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 11.14% | 33.16% | -22.02% |
MHIP vs. SBIO - Expense Ratio Comparison
MHIP has a 0.55% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Dividends
MHIP vs. SBIO - Dividend Comparison
Neither MHIP nor SBIO has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
MHIP Milliman Healthcare Inflation Plus ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
MHIP and SBIO have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SBIO is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.55% for MHIP.
MHIP and SBIO have nearly identical dividend yields, around 0.00%.
They also come from different issuers: Milliman and SS&C. Their fees differ too: 0.55% for MHIP and 0.50% for SBIO.
Find the right allocation for MHIP and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer